Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Appl Immunohistochem Mol Morphol. 2020 May-Jun;28(5):360–368. doi: 10.1097/PAI.0000000000000761

Figure 3.

Figure 3.

A. Overall survival analysis of all gastric tumors in respect to TNM stage. B. Overall survival analysis of all gastric tumors in respect of 5 subgroups. C. Overall survival analysis of all gastric tumors in respect of 3 subgroups. D. Overall survival analysis of EBV subgroups versus other tumors.